News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

Podcast: vNOTES (Vaginal Natural Orifice Transluminal Endoscopic Surgery)

In the latest episode of Back to HealthDr. Rochelle Joly delves into the revolutionary technique known as vaginal natural orifice transluminal endoscopic surgery (vNOTES). She explains the advantages that this minimally invasive method offers patients; including less pain, faster recovery, and fewer visible scars. Listen to the episode here.

Learn more about the Back to Health podcast here.

Dr. Virginia Pascual Elected to American Academy of Arts and Sciences

Virginia Pascual

Dr. Virginia Pascual, director of the Gale and Ira Drukier Institute for Children’s Health and the Ronay Menschel Professor of Pediatrics at Weill Cornell Medicine, has been elected to the American Academy of Arts and Sciences.       

Founded in 1780, the academy is one of the nation’s oldest honorary societies. Members have included Charles Darwin, Albert Einstein, Martin Luther King, Jr. and Barbara McClintock among a host of other luminaries. This year, Dr. Pascual joins nearly 250 other inductees from academia, the arts, industry, policy, research and science.       

“I’m in great company, and I’m very grateful and honored,” Dr. Pascual said. “The mission of the academy—to cultivate the interests, honor, dignity and happiness of a free, independent, and virtuous people—is beautiful and aspirational. I respect that spirit and could not be prouder to be a member of this community.”

How a Tiny RNA Modification Helps Control Cell Stress Responses

teal and brown molecular complexes

A tiny chemical modification commonly found on messenger RNAs plays a surprisingly large role in how cells respond to stress, according to a study led by Weill Cornell Medicine investigators.  The finding clarifies an important aspect of cell biology, and may have clinical implications, since this messenger RNA modification, known as m6A, is the target of an emerging class of cancer treatments.

Messenger RNA (mRNA)—the molecule that carries genetic instructions to make proteins—is often marked with m6A, a chemical modification that acts like a "disposal tag." Cell-survival and other stress-response messenger RNAs often contain many more m6As than average messenger RNAs.  Under normal conditions, this tag helps break down these messenger RNAs, keeping stress-response proteins at low levels.